Cited by 1,676Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerFerroptosis and cancer prognosis

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Hypoxia signalling in cancer and approaches to enforce tumour regression

Pouysségur, Jacques, Dayan, Frédéric, Mazure, Nathalie M.·2006·Nature

Open this paper in CoChat — free account

Abstract

Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.

Integrity signals

Registry

Crossref · 10.1038/nature04871

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653

Flagged first, then by citations

Show all 104 references

1 of the 104 references couldn’t be matched to a known paper.

Sorted by citations

Items 501–600 of 1,002

Protective Effect of Dl-3n-butylphthalide on Learning and Memory Impairment Induced by Chronic Intermittent Hypoxia-Hypercapnia Exposure
Min, J., Huo, X., Xiang, L.-Y., Qin, Y.-Q., Chai, K.-Q., Wu, B., Lu, J., & Wang, X. (2014) · Scientific Reports · doi:10.1038/srep05555 · Cited by 71
Metastasis and stem cell pathways
Barnhart, B. C., & Simon, M. C. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9053-3 · Cited by 74
Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards
Wilson, W. R., Hicks, K. O., Pullen, S. M., Ferry, D. M., Helsby, N. A., & Patterson, A. V. (2007) · Radiation Research · doi:10.1667/rr0807.1 · Cited by 71
VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases
Rad, F. H., Buanec, H. L., Paturance, S., Larcier, P., Genne, P., Ryffel, B., Bensussan, A., Bizzini, B., Gallo, R. C., Zagury, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611022104 · Cited by 77
PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia
Kang, X., Li, J., Zou, Y., Yi, J., Zhang, H., Cao, M., Yeh, E. T. H., & Cheng, J. (2010) · Oncogene · doi:10.1038/onc.2010.297 · Cited by 71
TRAILblazing Strategies for Cancer Treatment
Kretz, A.-L., Trauzold, A., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., von Karstedt, S., & Lemke, J. (2019) · Cancers · doi:10.3390/cancers11040456 · Cited by 71
Responsive agarose hydrogel incorporated with natural humic acid and MnO 2 nanoparticles for effective relief of tumor hypoxia and enhanced photo-induced tumor therapy
Hou, M., Liu, W., Zhang, L., Zhang, L., Xu, Z., Cao, Y., Kang, Y., & Xue, P. (2019) · Biomaterials Science · doi:10.1039/c9bm01472a · Cited by 70
p62-Induced Cancer-Associated Fibroblast Activation via the Nrf2-ATF6 Pathway Promotes Lung Tumorigenesis
Kang, J. I., Kim, D. H., Sung, K. W., Shim, S. M., Cha‐Molstad, H., Soung, N., Lee, K. H., Hwang, J., Lee, H. G., Kwon, Y. T., et al. (2021) · Cancers · doi:10.3390/cancers13040864 · Cited by 74
Nanoprobe-Based Magnetic Resonance Imaging of Hypoxia Predicts Responses to Radiotherapy, Immunotherapy, and Sensitizing Treatments in Pancreatic Tumors
Liu, J., Cabral, H., Song, B., Aoki, I., Chen, Z., Nishiyama, N., Huang, Y., Kataoka, K., & Mi, P. (2021) · ACS Nano · doi:10.1021/acsnano.1c04263 · Cited by 70
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Maggs, L., Sadagopan, A., Moghaddam, A. S., & Ferrone, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.07.006 · Cited by 76
Angiopoietin-Like Proteins Potential Therapeutic Targets for Metabolic Syndrome and Cardiovascular Disease
Oike, Y., & Tabata, M. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0710 · Cited by 70
Differential sensitivities to lactate transport inhibitors of breast cancer cell lines
Morais-Santos, F., Miranda‐Gonçalves, V., Pinheiro, S., Vieira, A. F., Paredes, J., Schmitt, F. C., Baltazar, F., & Pinheiro, C. M. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0132 · Cited by 70
Mitochondria and Cancer: Past, Present, and Future
Verschoor, M. L., Ungard, R. G., Harbottle, A., Jakupciak, J. P., Parr, R. L., & Singh, G. (2013) · BioMed Research International · doi:10.1155/2013/612369 · Cited by 69
Selectively Suppressing Tumor Angiogenesis for Targeted Breast Cancer Therapy by Genetically Engineered Phage
Li, Y., Qu, X., Cao, B., Yang, T., Bao, Q., Hui, Y., Zhang, L., Zhang, G., Wang, L., Qiu, P., et al. (2020) · Advanced Materials · doi:10.1002/adma.202001260 · Cited by 70
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 76
Salmonella ‐mediated tumor‐targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model
Chen, J., Yang, B., Cheng, X., Qiao, Y., Tang, B., Chen, G., Wei, J., Liu, X., Cheng, W., Du, P., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02147.x · Cited by 69
Role of Hypoxia-Inducible Factor α in Response to Hypoxia and Heat Shock in the Pacific Oyster Crassostrea gigas
Kawabe, S., & Yokoyama, Y. (2011) · Marine Biotechnology · doi:10.1007/s10126-011-9394-3 · Cited by 72
Tumour endothelial cells acquire drug resistance in a tumour microenvironment
Hida, K., Akiyama, K., Ohga, N., Maishi, N., & Hida, Y. (2013) · Journal of Biochemistry · doi:10.1093/jb/mvs152 · Cited by 68
Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine
Muscari, C., Giordano, E., Bonafè, F., Govoni, M., Pasini, A., & Guarnieri, C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-63 · Cited by 67
Chronic Inflammation and Colorectal Cancer: The Role of Vascular Endothelial Growth Factor
Hu, T., Li, L., Shen, J., Zhang, L., & Cho, C. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150514104244 · Cited by 68
Metabolic Reprogramming in Thyroid Carcinoma
Coelho, R. G., Fortunato, R. S., & de Carvalho, D. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00082 · Cited by 67
HIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 72
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis
Walia, V., Yu, Y., Cao, D., Sun, M., McLean, J. R., Hollier, B. G., Cheng, J., Mani, S. A., Rao, K., Premkumar, L. S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.392 · Cited by 69
HIF isoforms in the skin differentially regulate systemic arterial pressure
Cowburn, A. S., Takeda, N., Boutin, A. T., Kim, J., Sterling, J. C., Nakasaki, M., Southwood, M. R., Goldrath, A. W., Jamora, C., Nizet, V., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306942110 · Cited by 68
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
Hypoxia drives the assembly of the multienzyme purinosome complex
Doigneaux, C., Pedley, A. M., Mistry, I. N., Papayova, M., Benkovic, S. J., & Tavassoli, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012175 · Cited by 65
Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells
Peppicelli, S., Calorini, L., Bianchini, F., Papucci, L., Magnelli, L., & Andreucci, E. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00969-z · Cited by 72
Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activityPreprint
Wilkinson, S., O’Prey, J., Fricker, M., & Ryan, K. M. (2009) · Genes & Development · doi:10.1101/gad.521709 · Cited by 70
The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
Marín, V., Burgos, V., Pérez, R., Maria, D. A., Pardi, P. C., & Paz, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310737 · Cited by 66
Glycosidic carbonic anhydrase IX inhibitors: A sweet approach against cancer
Winum, J., Colinas, P. A., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.043 · Cited by 68
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack
Bulfoni, M., Turetta, M., Ben, F. D., Loreto, C. D., Beltrami, A. P., & Cesselli, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101775 · Cited by 66
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
Liu, Y., Bernauer, A. M., Yingling, C. M., & Belinsky, S. A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs142 · Cited by 65
Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses
Yoon, H., Shin, S.-H., Shin, D. H., Chun, Y., & Park, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.001 · Cited by 69
Impacts of Hypoxia-Inducible Factor-1 Knockout in the Retinal Pigment Epithelium on Choroidal Neovascularization
Lin, M., Hu, Y., Chen, Y., Zhou, K. K., Jin, J., Zhu, M., Le, Y.-Z., Ge, J., & Ma, J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8936 · Cited by 64
Histological mapping of biochemical changes in solid tumors by FT‐IR spectral imaging
Petibois, C., Drogat, B., Bikfalvi, A., Déléris, G., & Moenner, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.10.052 · Cited by 65
Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia
Endo, H., Okuyama, H., Ohue, M., & Inoue, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098858 · Cited by 67
Oxygen sensing and hypoxia-induced responses
Coleman, M. L., & Ratcliffe, P. J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430001 · Cited by 63
Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels
Parks, S. K., Mazure, N. M., Counillon, L., & Pouysségur, J. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24346 · Cited by 66
Self-citation
Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation
Toshima, T., Shirabe, K., Matsumoto, Y., Yoshiya, S., Ikegami, T., Yoshizumi, T., Soejima, Y., Ikeda, T., & Maehara, Y. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0835-9 · Cited by 63
COMMD1: A Multifunctional Regulatory Protein
Riera‐Romo, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26151 · Cited by 67
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Gérard, M., Corroyer‐Dulmont, A., Lesueur, P., Collet, S., Chérel, M., Bourgeois, M., Stefan, D., Limkin, E. J., Perrio, C., Guillamo, J., et al. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00117 · Cited by 64
Obesity-driven inflammation and cancer risk: A comprehensive review
Lamabadusuriya, D. A., Jayasena, H., Bopitiya, A. K., Silva, A. D. D., & Jayasekera, P. T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.007 · Cited by 68
Hypoxia-Mediated Metastasis
Chang, J., & Erler, J. T. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_3 · Cited by 67
Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
Sadri, N., & Zhang, P. J. (2013) · Cancers · doi:10.3390/cancers5020320 · Cited by 65
Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events
Lehmann, S., Stiehl, D. P., Honer, M., Dominietto, M. D., Keist, R., Kotevic, I., Wollenick, K., Ametamey, S. M., Wenger, R. H., & Rudin, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901194106 · Cited by 62
CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation
Nijkamp, M. W., Hoogwater, F. J. H., Steller, E. J. A., Westendorp, B. F., van der Meulen, T. A., Leenders, M. W. H., Rinkes, I. H. M. B., & Kranenburg, O. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.040 · Cited by 63
Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
Şahin, İ. H., Elias, H. K., Chou, J. F., Capanu, M., & O'Reilly, E. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4679-9 · Cited by 64
Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer
Zhang, J., Wu, Y., Lin, Y.-H., Guo, S., Ning, P.-F., Zheng, Z., Wang, Y., & Zhao, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2381 · Cited by 62
The Crosstalk of Adipose-Derived Stem Cells (ADSC), Oxidative Stress, and Inflammation in Protective and Adaptive Responses
Rochette, L., Mazini, L., Malka, G., Zeller, M., Cottin, Y., & Vergely, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239262 · Cited by 65
Tumour heterogeneity and evolutionary dynamics in colorectal cancer
Chan, D. K. H., & Buczacki, S. J. A. (2021) · Oncogenesis · doi:10.1038/s41389-021-00342-x · Cited by 62
Multidimensional transitional metal-actuated nanoplatforms for cancer chemodynamic modulation
Zhuang, Y., Han, S., Fang, Y., Huang, H. W., & Wu, J. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214360 · Cited by 62
Hypoxia-inducible factor-2α and TGF-β signaling interact to promote normoxic glomerular fibrogenesis
Hanna, C., Hubchak, S. C., Liang, X., Rozen‐Zvi, B., Schumacker, P. T., Hayashida, T., & Schnaper, H. W. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00155.2013 · Cited by 61
Hypoxia-Inducible Factor in Thyroid Carcinoma
Burrows, N., Babur, M., Resch, J., Williams, K. J., & Brabant, G. E. (2011) · Journal of Thyroid Research · doi:10.4061/2011/762905 · Cited by 66
A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light
Turan, I. S., Yıldız, D., Türksoy, A., Günaydın, G., & Akkaya, E. U. (2016) · Angewandte Chemie · doi:10.1002/ange.201511345 · Cited by 62
Genetics, epigenetics and pharmaco‐(epi)genomics in angiogenesis
Buysschaert, I., Schmidt, T., Roncal, C., Carmeliet, P., & Lambrechts, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00515.x · Cited by 64
Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes
Kao, S.-H., Wu, K., & Lee, W. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020024 · Cited by 64
New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy
Wang, G., Wang, J., Yin, P., Xu, K., Wang, Y., Shi, F., Gao, J., & Fu, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26917 · Cited by 61
Vitamin C Transporters and Their Implications in Carcinogenesis
Linowiecka, K., Foksiński, M., & Brożyna, A. A. (2020) · Nutrients · doi:10.3390/nu12123869 · Cited by 61
Glycolytic reprogramming in macrophages and MSCs during inflammation
Li, X., Shen, H., Zhang, M., Teissier, V., Huang, E. E., Gao, Q., Tsubosaka, M., Toya, M., Kushioka, J., Maduka, C. V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199751 · Cited by 64
Generation of Oxygen Deficiency in Cell Culture Using a Two-Enzyme System to Evaluate Agents Targeting Hypoxic Tumor Cells
Baumann, R. P., Penketh, P. G., Seow, H. A., Shyam, K., & Sartorelli, A. C. (2008) · Radiation Research · doi:10.1667/rr1431.1 · Cited by 61
MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells
Guo, X., Xue, H., Guo, X., Gao, X. C., Xu, S., Yan, S., Han, X., Li, T., Shen, J., & Li, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5871 · Cited by 60
Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
Lee, D. H., Thoennissen, N. H., Goff, C. B., Iwanski, G. B., Forscher, C. A., Doan, N., SAID, J. W., & Koeffler, H. P. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.001 · Cited by 63
Functional features of cancer stem cells in melanoma cell lines
Zimmerer, R. M., Korn, P., Demougin, P., Kampmann, A., Kokemüller, H., Eckardt, A. M., Gellrich, N., & Tavassol, F. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-78 · Cited by 60
Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia
Tiziani, S., Kang, Y., Harjanto, R., Axelrod, J. L., Piermarocchi, C., Roberts, W. D., & Paternostro, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082859 · Cited by 60
Hypoxia Promotes Gastric Cancer Malignancy Partly through the HIF-1α Dependent Transcriptional Activation of the Long Non-coding RNA GAPLINC
Liu, L., Zhao, X., Zou, H., Bai, R., Yang, K., & Tian, Z. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00420 · Cited by 60
Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect
Pereira‐Nunes, A., Afonso, J., Granja, S., & Baltazar, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_3 · Cited by 63
Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer
Wu, J., Yi, S., Cao, Y., Zu, M., Li, B., Yang, W. J., Shahbazi, M., Wan, Y., Reis, R. L., Kundu, S. C., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122332 · Cited by 59
Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion
Zhang, S., Wang, Y., & Li, S. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.127 · Cited by 59
Past, Present, and Future of Molecular and Cellular Oncology
Galluzzi, L., Vitale, I., & Kroemer, G. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00001 · Cited by 62
Mitochondria and cancer
Máximo, V., Lima, J. P., Soares, P., & Sobrinho-Simões, M. A. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0766-2 · Cited by 60
Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Deep, G., & Agarwal, R. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990041 · Cited by 59
Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes
Sadeghi, R. N., Karami‐Tehrani, F., & Salami, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2919-4 · Cited by 59
HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration
Fitsialos, G., Bourget, I., Augier, S., Ginouvès, A., Rezzonico, R., Odorisio, T., Cianfarani, F., Virolle, T., Pouysségur, J., Meneguzzi, G., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.029256 · Cited by 58
Self-citation
Targeting tumor hypoxia in nasopharyngeal carcinoma
Hong, B., Lui, V. W. Y., Hashiguchi, M., Hui, E. P., & Chan, A. T. �. (2011) · Head & Neck · doi:10.1002/hed.21877 · Cited by 58
Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene CPT1C to Promote Survival
Reilly, P. T., & Mak, T. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3281 · Cited by 62
Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
Dratkiewicz, E., Simiczyjew, A., Mazurkiewicz, J., Ziętek, M., Matkowski, R., & Nowak, D. (2021) · Cells · doi:10.3390/cells10040862 · Cited by 65
A biophysically based mathematical model for the catalytic mechanism of glutathione reductase
Pannala, V. R., Bazil, J. N., Camara, A. K. S., & Dash, R. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.001 · Cited by 58
Short‐Term Hypoxia Enhances the Migratory Capability of Dendritic Cell Through HIF‐1α and PI3K/Akt Pathway
Filippi, I., Morena, E., Aldinucci, C., Carraro, F., Sozzani, S., & Naldini, A. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24666 · Cited by 59
Hypoxia improves expansion potential of human cord blood–derived hematopoietic stem cells and marrow repopulation efficiency
Roy, S., Tripathy, M., Mathur, N., Jain, A., & Mukhopadhyay, A. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01759.x · Cited by 58
Crohn disease-associated Escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses
Mimouna, S., Gonçalvès, D., Barnich, N., Darfeuille–Michaud, A., Hofman, P. M., & Vouret‐Craviari, V. (2011) · Gut Microbes · doi:10.4161/gmic.18771 · Cited by 58
The Hypoxic Tumor Microenvironment: Driving the Tumorigenesis of Non-Small-Cell Lung Cancer
Foster, J. G., Wong, S. C. K., & Sharp, T. V. (2014) · Future Oncology · doi:10.2217/fon.14.201 · Cited by 61
Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression
Anderson, T. M. R., Peacock, D. L., Daniel, A. R., Hubbard, G. K., Lofgren, K. A., Girard, B. J., Schörg, A., Hoogewijs, D., Wenger, R. H., Seagroves, T. N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0523 · Cited by 58
Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris, M. R., Hughes, D. J., Tian, Y.-M., Ricketts, C. J., Lau, K. W., Gentle, D., Shuib, S., Serrano‐Fernández, P., Lubiński, J., Wiesener, M. S., et al. (2009) · PubMed · Cited by 58
miR‐17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia‐Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation
Chen, T., Zhou, Q., Tang, H., Bozkanat, K. M., Yuan, J. X. ‐., Raj, J. U., & Zhou, G. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004510 · Cited by 58
Roles of Mir-200 Family Members in Lung Cancer: More Than Tumor Suppressors
Liu, C., Hu, W., Li, L.-L., Wang, Y., Zhou, Q. Y., Zhang, F., Songyang, Y., Zhu, W., Sun, C., & Li, D. (2018) · Future Oncology · doi:10.2217/fon-2018-0155 · Cited by 59
Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells
Yoshida, T., Hashimura, M., Mastumoto, T., Tazo, Y., Inoue, H., Kuwata, T., & Saegusa, M. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.111 · Cited by 58
Targeting obesity-related dysfunction in hormonally driven cancers
Rubinstein, M. M. Z., Brown, K. A., & Iyengar, N. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01393-y · Cited by 61
Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis
Li, L., Huang, K., You, Y., Fu, X., Hu, L., Song, L., & Meng, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2368 · Cited by 59
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma
Li, Y., Yang, H., Luo, R.-Z., Zhang, Y., Li, M., Wang, X., & Jia, W.-H. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.12.012 · Cited by 57
Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration
Chiche, J., Ilc, K., Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.005 · Cited by 58
Self-citation
Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
Dalès, J.-P., Beaufils, N., Silvy, M., Picard, C., Pauly, V., Pradel, V., Formisano‐Tréziny, C., Bonnier, P., Giusiano, S., Charpin, C., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-44 · Cited by 57
HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
Lp, L., Hu, B., Ye, C., Ho, R. L. K., Chen, G. G., & Lai, P. B. S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.787 · Cited by 57
Regulation of transcription of hypoxia-inducible factor-1α (HIF-1α) by heat shock factors HSF2 and HSF4
Chen, R., Liliental, J., Kowalski, P., Lu, Q., & Cohen, S. N. (2011) · Oncogene · doi:10.1038/onc.2010.623 · Cited by 57
Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability
Knaup, K. X., Jozefowski, K., Schmidt, R., Bernhardt, W. M., Weidemann, A., Jürgensen, J. S., Warnecke, C., Eckardt, K., & Wiesener, M. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0288 · Cited by 56
Regulation of the endothelial cell cycle by the ubiquitin-proteasome system
Fasanaro, P., Capogrossi, M. C., & Martelli, F. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp244 · Cited by 60
“Smart” Nanoprobes for Visualization of Tumor Microenvironments
Ma, T., Zhang, P., Hou, Y., Ning, H., Wang, Z., Huang, J., & Gao, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800391 · Cited by 58
Hypoxia-degradable zwitterionic phosphorylcholine drug nanogel for enhanced drug delivery to glioblastoma
She, D., Huang, H., Li, J., Peng, S., Wang, H., & Yu, X. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127359 · Cited by 56
Hypoxia and HIF-1α expression in the epiphyseal cartilage following ischemic injury to the immature femoral head
Kim, H. K. W., Bian, H., Aya-ay, J., Garces, A. H., Morgan, E. F., & Gilbert, S. R. (2009) · Bone · doi:10.1016/j.bone.2009.03.665 · Cited by 56
EGFR and microvessel density in canine malignant mammary tumours
Carvalho, M. I., Guimarães, M. J., Pires, I. C. R., Prada, J., Silva-Carvalho, R., Lopes, C., & QUEIROGA, F. L. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.09.003 · Cited by 56
Glycosaminoglycans in cancer treatment
Belting, M. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50016-3 · Cited by 56

Authors: Pouysségur, J., Dayan, F., & Mazure, N. M.
Affiliations: Centre National de la Recherche Scientifique (FR)
Corresponding author: Pouysségur, Jacques
ORCID: Pouysségur, Jacques
Mazure, Nathalie M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-05-24
Volume: 441
Issue: 7092
Pages: 437-443
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04871
OpenAlex: W2082483448
Semantic Scholar: 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
Cited by: 1,676
References: 104
Citations by year: 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
FWCI: 6.91
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Ligue Contre le Cancer
Centre National de la Recherche Scientifique
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords: hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia signalling in cancer and approaches to enforce tumour regression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks